1. Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial. Issue 5 (May 2022) Authors: Ruel, Theodore D; Acosta, Edward P; Liu, Jessica P; Gray, Kathryn P; George, Kathleen; Montañez, Nicole; Popson, Stephanie; Buchanan, Ann M; Bartlett, Mattie; Dayton, Dale; Anthony, Patricia; Brothers, Cynthia; Vavro, Cynthia; Singh, Rajendra; Koech, Lucy; Vhembo, Tichaona; Mmbaga, Blandina T; Pi... Journal: Lancet Issue: Volume 9:Issue 5(2022) Page Start: e332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗